|
Morgan Keegan Disclosures |
ADDITIONAL INFORMATION AVAILABLE UPON REQUEST
For important information about our disclosures
http://mk.bluematrix.com/bluematrix/Disclosure
As of the date of this report, Morgan Keegan & Co., Inc. makes a market in
these securities: ASEI, CDCY, COGT, DMRC, LCRD, FADV, FLIR, IDNX, IDSY, INGR,
OSIS, VRNT.
Morgan Keegan & Co., Inc. has received compensation for investment banking
services from OSIS and CDCY in the past 12 months.
Morgan Keegan & Co., Inc. expects to receive or intends to seek compensation
for investment banking services from these companies in the next 3 months:
ASEI, CDCY, COGT, DMRC, FADV, LCRD, IDNX, IDSY, OSIS, RAE, and VRNT.
A company affiliated with Morgan Keegan & Co., Inc. holds warrants of IDNX
and LCRD.
MK was the lead underwriter for a secondary transaction for 2,750,000 shares
of IDSY, completed on March 10, 2006 at $21.75/share.
Morgan Keegan & Co., Inc. does and seeks to do business with companies
covered in its research reports. As a result, investors should be aware that
the firm may have a conflict of interest that could affect the objectivity
of this report.
Investors should consider this report as only a single factor in making
their investment decision.
MK PERFORMANCE RATINGS
O-Outperform (Expected to outperform the S & P 500* over the next 6 months)
M-Market Perform (Expected to perform the S & P 500* over the next 6 months)
U-Underperform (Expected to underperform the S & P 500* over the next 6
months)
*REIT’s performance benchmark is total return to the NAREIT Equity Index.
MK SUITABILITY RATINGS
S-Speculative (Business or balance sheet risk materially above that of the
average U.S. public company)
M-Market Risk (Business or balance sheet risk not materially different from
that of the average U.S. public company)
C-Conservative (Business or balance sheet risk materially below that of the
average U.S. public company)
DISCLOSURE STATEMENT: The information contained in this report is based on
sources considered to be reliable but is not represented to be complete and
its accuracy is not guaranteed. The opinions expressed reflect the judgment
of the author as of the date of publication and are subject to change
without notice. This report does not constitute an offer to sell or a
solicitation of an offer to buy any securities. Morgan Keegan & Co., Inc., a
subsidiary of Regions Financial Corporation, and its officers, directors,
shareholders and employees, other than the research analyst responsible for
the preparation of this report, and affiliates and members of their families
may have positions in these securities and may, as principal or agent, buy
and sell such securities before, after or concurrently with the publication
of this report. In some instances, such investments may be inconsistent with
the opinions expressed herein. An employee, other than the research analyst
responsible for the preparation of this report, may be a member of the board
of directors for companies referred to in this report. The research analyst
responsible for the preparation for this report is compensated based in part
on the firm's investment banking revenue but is not compensated upon
specific investment banking services transactions. Morgan Keegan & Co.,
Inc., member NYSE, NASD and SIPC, is a registered broker-dealer subsidiary
of Regions Financial Corporation. Investments are NOT FDIC INSURED, NOT BANK
GUARANTEED and MAY LOSE VALUE. For more information about Morgan Keegan
disclosures, please go to http://mk.bluematrix.com/bluematrix/Disclosure? To
obtain a copy of the most recent disclosure information regarding the
individual securities mentioned in this compendium report, please write to
us at the following address: Equity Research Department Attn: Director of
Research Morgan Keegan & Co., Inc. 50 N. Front Street - 13th floor Memphis,
TN 38103
|
|
